Procedures

Enzyme
assay. All creatine kinase activity measurements were made at 37 #{176}C by the Rosalki-Oliver method (12) by use of"CPK-Fast Paks" (Calbiochem, San Diego, CA 92112). The reaction was monitored with a Unicam SP 1700 Spectrophotometer (Canadian Laboratory Supplies Ltd., Toronto, Ontario, Canada) equipped with a Hetofrig Bath (Canadian Laboratory Supplies Ltd.) for cuvette temperature control. CK-1 activity, in column eluates, was assayed by the immunoinhibition technique of Gerhardt et al. (13) with the Merck anti-human creatine BB (CK-1) serum from sheep (BDH Chemicals Canada Ltd., Toronto).
CK isoenzyme estimations.
These were done by use of mini-columns of DEAE-cellulose (14) or by agarose gel electrophoresis (Beckman Instruments, Inc., Fullerton, CA 92634).
Purification of immunoglobulins.
The IgG and 1gM from the commercial preparation of human immunoglobulins (Connaught Laboratories Ltd., Toronto) were separated, at room temperature, on a 25 X 900 mm column of Sephadex G-200 (Pharmacia, Canada, Ltd.) with use of an eluent consisting of 50 mmol/L Tris.HCI buffer (pH 7.0 at 25 #{176}C) containing 10 mmol of NaCI per litre. The purity of each immunoglobulin pool was confirmed by radial immunodiffusion and by electrophoresis on polyacrylamide gel. The immunoglobulins were dialyzed against a 3-L volume of elution buffer for 24 h at 4#{176}C, and small lyophilized fractions were stored at -80 #{176}C. Before experiments the material was reconstituted in water. 
Estimation
Purification of the human CK isoenzyme-1.
Human brain was used as a source of CK-1. Brain was homogenized in 100 mmol/L XCI (1 g wet weight in 2 mL) containing 5 mmol of 2-mercaptoethanol per litre and clarified by passage through four layers of cheesecloth, followed by centrifugation of the filtrate (1300 X g, 30 mm, 5 #{176}C). Subsequently, this crude extract was purified essentially as described by Keutel et al. (17) . For final separation of the CX isoenzymes we used a 9 X 300 mm medium-mesh DEAE-cellulose column with stepwise elution as previously described (14) . Electrophoresis on polyacrylamide gel was used to confirm that the CK-1 was homogeneous. The isoenzyme preparation was dialyzed against the above-mentioned Tris/NaCl buffer for 96 h at 4 or in the presence of 15 
Fast gel chromatography.
A 25 X 930 mm column of Sephacryl S-200 Superfine (Pharmacia (Canada) Ltd.) was used at 4#{176}C with an eluting buffer of 50 mmol/L Tris.HC1 (pH 7.0 at 25#{176}C) containing, per litre, 10 mmolofNaCl, 10 mmol of thioglycerol, and 2 mmol of disodium ethylenediaminetetraacetate (EDTA) to stabilize any CX activity present on the column. Separations were achieved at a flow rate of 37.5 mL/h, i.e., a chromatographic separation was complete within 5 h.
Patients' Sera
Serum was obtained from each of two proven cases of myocardial infarction with an elevated serum CK-2 activity and from four patients who had undergone clipping of an intra-cranial aneurysm within the previous 18 h. We diluted 1.5 niL of serum with an equal volume of 100 mmol/L Tris.HC1 buffer (pH 7.0 at 25 #{176}C) and concentrated it in a Model 3 stirred cell (Amicon Canada Ltd., Oakville, Ontario) containing the XM-300 membrane (exclusion limit, 300 000) for about 2 h at room temperature. The volume of serum was reduced to about 500 L, and 500 L of untreated serum from the same patient was added to it. This total volume was then applied to the Biogel A 1.5M column described under Determinations of relative molecular mass.
Results
When pure human CK-1 is incubated in the presence of increasing amounts of human IgG, there is a marked, concentration-dependent decrease in enzyme activity with time ( Figure 1 ). This result contrasts with earlier work, where it was shown that pure human monomeric albumin considerably stabilizes CK-1 under similar conditions (2). If the experiment is repeated using a fast-separation (S-200) gel-which lacks the resolving power of the slower G-200 gel-then it is clear that the third species has creatine kinase activity (Figure 3 ).
This CK-1-IgG complex was found to have a relative molecular mass (Figures 4 and 5 The stability of the CK-1-IgG complex and free (i.e., uncomplexed) CK-1 were examined with use of just-eluted fractions in the experiments shown in Figures 3 and 9 . The data in Table 1 demonstrate the extreme lability of the enzyme activity of the CX-1-IgG complex as compared to the activity of free CX-! stored under similar conditions. Examination of fractions from the three protein peaks in Figures 3 and 9 for the presence of IgG makes it clear ( Figure  10 ) that only the IgG peak and the peak containing the CX-1-IgG complex include detectable IgG.
Discussion
We have demonstrated the existence of a CK-1-IgG complex in vitro. This complex has an approximate relative molecular mass of 825 000, and it contains both lgG and CK-1.
The relative molecular masses of human creatine kinase and (Table 1) explains why we were unable to find en- The three fractions used in each experiment were obtained from fractions corresponding to the peaks shown in Figures 3 (expt. A) and 9 (expt. B) . 10 pL of CK-l-lgG complex. Wells 1 and 8 contained 5 p1 of the PgGstandard (310 pg/pL). The plate was subjected to 200 V for 90 mm. then stained with the Worthington dichrome strain Despite these precautions the complex was found ( Table  1) complex is also extremely transient, and in turn it seems an obvious proposal that this is a mechanism for the inactivation of serum CX-!. Morin (26) showed that creatine kinase activity disappeared in vitro from serum in rates similar to reported in vivo rates, and he concluded that CX inactivation must primarily be thermal in nature. Our findings suggest a route by which CK-1 activity disappears from blood.
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